Other languages Co-Diagnostics, Inc.

Equities

CODX

US1897631057

Real-time Estimate Cboe BZX Other stock markets 11:52:25 2024-05-07 am EDT			5-day change	1st Jan Change
1.29 ^USD	+2.38%		+11.21%	-3.01%

Apr. 12	Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event	CI
Apr. 04	Co-Diagnostics, Inc. Appoints Executive Appointments	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event	Apr. 12
Co-Diagnostics, Inc. Appoints Executive Appointments	Apr. 04
Co-Diagnostics, Inc. Appoints Richard Abbott as President	Mar. 15
Co-Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14
Co-Diagnostics Gets Approval From India's Central Drugs Standard Control Organization For Manufacturing, Sale of Influenza Multiplex Test	Mar. 07
Co-Diagnostics Submits PCR COVID-19 Test and PCR Pro Instrument for FDA Review	Dec. 27
Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro	Dec. 27
Co-Diagnostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09
Co-Diagnostics, Inc. Appoints Ivory Chang as Chief Regulatory Affairs Officer	23-08-29
Co-Diagnostics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10
Co-Diagnostics Wins Gates Foundation Grants for Tuberculosis, HPV Tests	23-07-18
Co-Diagnostics, Inc. Announces Recent Grant Awards	23-07-18
Co-Diagnostics Receives $1.2 Million in New Funds From National Institutes of Health	23-07-13
Co-Diagnostics, Inc. Receives Funding for Co-Dx PCR Home Platform from NIH RADx Tech Program	23-07-13
Co-Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11
Sector Update: Health Care Stocks Slip Pre-Bell Friday	23-03-17
Co-Diagnostics Files $150 Million Mixed Shelf	23-03-17
Co-Diagnostics, Inc. Initiates Clinical Evaluations for At-Home and Point-of-Care Co Dx PCR Home(TM) Platform	23-02-22
Co-Diagnostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10
Earnings Reaction History: Co-Diagnostics Inc, 60.0% Follow-Through Indicator, 17.0% Sensitive	22-11-10

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Co-Diagnostics, Inc.

Equities

CODX

US1897631057

Other languages

Filters